|
Today's Headlines
Sarilumab may be an effective option for patients with moderately-to-severely active rheumatoid arthritis (RA)—including those who have had an inadequate response to, or were intolerant of, 1 or more TNF-alpha inhibitors (TNF-IR) or inadequate response to methotrexate, according to topline results from a new study.
» New RA therapies needed
|
|
Because lung function can be substantially reduced by the time most chronic obstructive pulmonary disease (COPD) patients first see a physician, maintenance treatment should be considered at the time of diagnosis, according to new data analyses presented at the American Thoracic Society (ATS) 2015 International Conference.
» Data details
|
Continuing Education
This month's CE activity is part of the CE series, MTM for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.
The goal of this month's activity is to review the stepwise approach to the management of pediatric and adult asthma and the pharmacotherapies commonly used in asthma treatment.
To read and print the article with TEST questions, click here.
To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT30-PYJ23.
Announcement: The login to the Online CE Center is
https://web2.uconn.edu/pharmacyce/login.php. All current user registration has been uploaded for your convenience. Current users do not need to register. To review you registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/
|
|
EDITOR'S PICK
As the White House pushes for better antibiotic stewardship, it's important to know which antibiotics are the most overused. » Get the list here
|
|
|
Like
Tweet
